Global High-Throughput Screening Market Overview 2023-2028
The global high-throughput screening market size reached US$ 23.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 38.3 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.
High-throughput screening (HTS) is a method used in scientific research and drug discovery to rapidly test a large number of chemical compounds or biological agents for specific activities. It comprises the automated testing of numerous samples, allowing researchers to identify promising candidates for further study. It accelerates the process of drug discovery and research while enabling the screening of a vast number of compounds in a short time, reducing the time required to identify potential leads. It saves money by reducing the need for manual labor and resources and enhances decision-making and helps prioritize further research efforts. It generates extensive data sets, providing researchers with valuable insights into the biological activity of compounds. It also allows for the testing of diverse chemical libraries, encouraging innovation by identifying compounds that may have been overlooked using traditional methods. As it aids in the identification of novel drug targets and the validation of existing ones, the demand for HTS is rising across the globe.
Global High-Throughput Screening Market Trends and Drivers:
The rising demand for innovative drugs to treat complex diseases represents one of the key factors supporting the growth of the market. HTS accelerates the identification of potential drug candidates, reducing research and development (R&D) timelines. In addition, expanding fields of genomics and proteomics are catalyzing the demand for HTS to analyze vast amounts of genetic and protein data quickly. Moreover, governing agencies and private organizations of several countries are investing in life sciences research, particularly in areas like personalized medicine and rare diseases, which is propelling the growth of the market. Apart from this, the shift towards precision medicine, where treatments are tailored according to the genetic makeup of an individual, relies on comprehensive genetic and molecular profiling. This, in turn, is offering lucrative growth opportunities to industry investors. Furthermore, the increasing prevalence of chronic diseases necessitates the discovery of new drugs and therapies, which is bolstering the market growth.
Global High-Throughput Screening Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are:
Agilent Technologies Inc., Aurora Biomed Inc., Axxam S.p.A, Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc., Charles River Laboratories International Inc., Corning Incorporated, Luminex Corporation (DiaSorin), Perkinelmer Inc., Sygnature Discovery, Tecan Group Ltd. and Thermo Fisher Scientific.
The report segmented the market on the basis of region, technology, products and services, applications and end user.
Breakup by Technology:
- Ultra-High-Throughput Screening
- Cell-Based Assays
- Lab-on-a-Chip
- Label-Free Technology
Breakup by Products and Services:
- Instruments
- Reagents and Kits
- Services
Breakup by Applications:
- Target Identification and Validation
- Primary and Secondary Screening
- Toxicology Assessment
- Others
Breakup by End User:
- Pharmaceutical and Biotechnology Firms
- Academic and Government Institutes
- Contract Research Organizations
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
